Consensus EPS · Q3 2026
$2.63
Consensus revenue · Q3 2026
$2.9B
Analysts
16
Expected report
Oct 20, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 16 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $2.8B | $2.9B | $3B |
| EPS | $2.53 | $2.63 | $2.76 |
| EBITDA | $1B | $1B | $1.1B |
| EBIT | $866.1M | $878.3M | $893.5M |
| Net income | $892.8M | $943.8M | $976.6M |
- Revenue$2.9B
- EPS$2.63
- EBITDA$1B
- EBIT$878.3M
- Net income$943.8M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | $2.9B | $2.8B | +2.4% | $2.80 | $2.51 | +11.5% |
| Q1 2026 | $2.8B | $2.6B | +5.8% | $2.50 | $2.12 | +17.8% |
- Q2 2026+2.4%+11.5%
- Q1 2026+5.8%+17.8%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Intuitive Surgical (ISRG) Q3 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 15 analysts.
- Low
- $400.00
- Consensus
- $525.00
- Median
- $505.00
- High
- $750.00
- Current
- $340.69
- Upside
- +54.1%
Upside calculated vs most recent trading price of $340.69.
Analyst ratings
Consensus: Buy — based on 56 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 17, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Jul 17, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 17, 2026 | Stifel | maintain | Buy | Buy |
| Jul 17, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 17, 2026 | Raymond James | maintain | Outperform | Outperform |
| Jul 17, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 17, 2026 | Mizuho | maintain | Neutral | Neutral |
| Jul 17, 2026 | Leerink Partners | maintain | Outperform | Outperform |
| Jul 17, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Jul 17, 2026 | Evercore ISI Group | maintain | In Line | In Line |
- Jul 17, 2026Wells FargoOverweight
- Jul 17, 2026TD CowenBuy
- Jul 17, 2026StifelBuy
- Jul 17, 2026RBC CapitalOutperform
- Jul 17, 2026Raymond JamesOutperform
- Jul 17, 2026Piper SandlerOverweight
- Jul 17, 2026MizuhoNeutral
- Jul 17, 2026Leerink PartnersOutperform
- Jul 17, 2026JP MorganOverweight
- Jul 17, 2026Evercore ISI GroupIn Line
Frequently asked questions
Intuitive Surgical (ISRG) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.